|
1
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang Y, Jahagirdar BN, Reinhardt RL,
Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund
T, Blackstad M, et al: Pluripotency of mesenchymal stem cells
derived from adult marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Charbord P: Bone marrow mesenchymal stem
cells: Historical overview and concepts. Hum Gene Ther.
21:1045–1056. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oreffo RO, Cooper C, Mason C and Clements
M: Mesenchymal stem cells: Lineage, plasticity and skeletal
therapeutic potential. Stem Cell Rev. 1:169–178. 2005. View Article : Google Scholar
|
|
8
|
Hwa Cho H, Bae YC and Jung JS: Role of
toll-like receptors on human adipose-derived stromal cells. Stem
Cells. 24:2744–2752. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van den Berk LC, Jansen BJ,
Siebers-Vermeulen KG, Netea MG, Latuhihin T, Bergevoet S, Raymakers
RA, Kögler G, Figdor CC, Adema GJ and Torensma R: Toll-like
receptor triggering in cord blood mesenchymal stem cells. J Cell
Mol Med. 13:3415–3426. 2009. View Article : Google Scholar
|
|
10
|
Wang X, Cheng Q, Li L, Wang J, Xia L, Xu X
and Sun Z: Toll-like receptors 2 and 4 mediate the capacity of
mesenchymal stromal cells to support the proliferation and
differentiation of CD34+cells. Exp Cell Re. 318:196–206. 2012.
View Article : Google Scholar
|
|
11
|
Benakanakere MR, Li Q, Eskan MA, Singh AV,
Zhao J, Galicia JC, Stathopoulou P, Knudsen TB and Kinane DF:
Modulation of TLR2 protein expression by miR-105 in human oral
keratinocytes. J Biol Chem. 284:23107–23115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Quinn EM, Wang JH, O'Callaghan G and
Redmond HP: MicroRNA-146a is upregulated by and negatively
regulates TLR2 signaling. PLoS One. 8:e622322013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
O'Hara SP, Splinter PL, Gajdos GB,
Trussoni CE, Fernandez-Zapico ME, Chen XM and LaRusso NF: NFkappaB
p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated
transcriptional repression of microRNA let-7i following microbial
infection. J Biol Chem. 285:216–225. 2010. View Article : Google Scholar :
|
|
14
|
Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu
J, Sun Z and Shen WF: MiR-146a inhibits oxidized low-density
lipoprotein-induced lipid accumulation and inflammatory response
via targeting toll-like receptor 4. FEBS Lett. 585:854–860. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tili E, Michaille JJ, Cimino A, Costinean
S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA and
Croce CM: Modulation of miR-155 and miR-125b levels following
lipopolysaccharide/TNF-alpha stimulation and their possible roles
in regulating the response to endotoxin shock. J Immunol.
179:5082–5089. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Curtale G, Mirolo M, Renzi TA, Rossato M,
Bazzoni F and Locati M: Negative regulation of Toll-like receptor 4
signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci USA.
110:11499–11504. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ceppi M, Pereira PM, Dunand-Sauthier I,
Barras E, Reith W, Santos MA and Pierre P: MicroRNA-155 modulates
the interleukin-1 signaling pathway in activated human
monocyte-derived dendritic cells. Proc Natl Acad Sci USA.
106:2735–2740. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Hwa Cho H, Bae YC and Jung JS: Role of
toll-like receptors on human adipose-derived cells. Stem Cells.
24:2744–2752. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pevsner-Fischer M, Morad V, Cohen-Sfady M,
Rousso-Noori L, Zanin-Zhorov A, Cohen S, Cohen IR and Zipori D:
Toll-like receptors and their ligands control mesenchymal stem cell
functions. Blood. 109:1422–1432. 2007. View Article : Google Scholar
|
|
21
|
Liotta F, Angeli R, Cosmi L, Filì L,
Manuelli C, Frosali F, Mazzinghi B, Maggi L, Pasini A, Lisi V, et
al: Toll-like receptors 3 and 4 are expressed by human bone
marrow-derived mesenchymal stem cells and can inhibit their T cell
modulatory activity by 634 impairing Notch signaling. Stem Cells.
26:279–289. 2008. View Article : Google Scholar
|
|
22
|
Opitz CA, Litzenburger UM, Lutz C, Lanz
TV, Tritschler I, Köppel A, Tolosa E, Hoberg M, Anderl J, Aicher
WK, et al: Toll-like receptor engagement enhances the
immunosuppressive properties of human bone marrow-derived
mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1
via interferon-beta and protein kinase R. Stem Cells. 27:909–919.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tomchuck SL, Zwezdaryk KJ, Coffelt SB,
Waterman RS, Danka ES and Scandurro AB: Toll-like receptors on
human mesenchymal stem cells drive their migration and
immunomodulating responses. Stem Cells. 26:99–107. 2008. View Article : Google Scholar
|
|
24
|
Romieu-Mourez R, François M, Boivin MN,
Bouchentouf M, Spaner DE and Galipeau J: Cytokine modulation of TLR
expression and activation in mesenchymal stromal cells leads to a
proinflammatory phenotype. J Immunol. 182:7963–7973. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
White NM, Bao TT, Grigull J, Youssef YM,
Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, et
al: miRNA profiling for clear cell renal cell carcinoma: Biomarker
discovery and identification of potential controls and consequences
of miRNA dysregulation. J Urol. 186:1077–1083. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma J, Liu J, Wang Z, Gu X, Fan Y, Zhang W,
Xu L, Zhang J and Cai D: NF-kappaB-dependent MicroRNA-425
upregulation promotes gastric cancer cell growth by targeting PTEN
upon IL-1β induction. Mol Cancer. 13:402014. View Article : Google Scholar
|
|
27
|
Laine SK, Alm JJ, Virtanen SP, Aro HT and
Laitala-Leinonen TK: MicroRNAs miR-96, miR-124 and miR-199a
regulate gene expression in human bone marrow-derived mesenchymal
stem cells. J Cell Biochem. 113:2687–2695. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen J, Liu Z and Yang Y: In vitro
screening of LPS-induced miRNAs in leukocytes derived from cord
blood and their possible roles in regulating TLR signals. Pediatr
Res. 75:595–602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Akiyama H: Control of chondrogenesis by
the transcription factor Sox9. Mod Rheumatol. 18:213–219. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin EA, Kong L, Bai XH, Luan Y and Liu CJ:
miR-199a, a bone morphogenic protein 2-responsive MicroRNA,
regulates chondrogenesis via direct targeting to Smad1. J Biol
Chem. 284:11326–11335. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu ZY, Lu L, Liang J, Guo XR, Zhang PH and
Luo SJ: Keloid microRNA expression analysis and the influence of
miR-199a-5p on the proliferation of keloid fibroblasts. Genet Mol
Res. 13:2727–2738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shi XE, Li YF, Jia L, Ji HL, Song ZY,
Cheng J, Wu GF, Song CC, Zhang QL, Zhu JY and Yang GS:
MicroRNA-199a-5p affects porcine preadipocyte proliferation and
differentiation. Int J Mol Sci. 15:8526–8538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feng Y, Cao JH, Li XY and Zhao SH:
Inhibition of miR-214 expression represses proliferation and
differentiation of C2C12 myoblasts. Cell Biochem Funct. 29:378–383.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang ZC, Li YY, Wang HY, Fu S, Wang XP,
Zeng MS, Zeng YX and Shao JY: Knockdown of miR-214 promotes
apoptosis and inhibits cell proliferation in nasopharyngeal
carcinoma. PLoS One. 9:e861492014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Derfoul A, Juan AH, Difilippantonio MJ,
Palanisamy N, Ried T and Sartorelli V: Decreased microRNA-214
levels in breast cancer cells coincides with increased cell
proliferation, invasion and accumulation of the Polycomb Ezh2
methyltransferase. Carcinogenesis. 32:1607–1614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Brzezianska E and Pastuszak-Lewandoska D:
A minireview: The role of MAPK/ERK and PI3K/Akt pathways in thyroid
follicular cell-derived neoplasm. Front Biosci (Landmark Ed).
16:422–439. 2011. View
Article : Google Scholar
|
|
39
|
Nahid MA, Yao B, Dominguez-Gutierrez PR,
Kesavalu L, Satoh M and Chan EK: Regulation of TLR2-mediated
tolerance and cross-tolerance through IRAK4 modulation by miR-132
and miR-212. J Immunol. 190:1250–1263. 2013. View Article : Google Scholar :
|
|
40
|
Ahmed F, Shiraishi T, Vessella RL and
Kulkarni P: Tumor necrosis factor receptor associated factor-4: An
adapter protein overexpressed in metastatic prostate cancer is
regulated by microRNA-29a. Oncol Rep. 30:2963–2968. 2013.PubMed/NCBI
|
|
41
|
Chen R, Alvero AB, Silasi DA, Kelly MG,
Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T and Mor G:
Regulation of IKKB by miR-199a affects NF-kappB activity in ovarian
cancer cells. Oncogene. 27:4712–4723. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou R, O'Hara SP and Chen XM: MicroRNA
regulation of innate immune responsesin epithelial cells. Cell Mol
Immunol. 8:371–379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang Z, Chen X, Yu B and Chen D: Cloning
and functional characterization of rat stimulator of interferon
genes (STING) regulated by miR-24. Dev Comp Immunol. 37:414–420.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lai NS, Yu HC, Chen HC, Yu CL, Huang HB
and Lu MC: Aberrant expression of microRNAs in T cells from
patients with ankylosing spondylitis contributes to the
immunopathogenesis. Clin Exp Immunol. 173:47–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao J, Gong AY, Zhou R, Liu J, Eischeid
AN and Chen XM: Downregulation of PCAF by miR-181a/b provides
feedback regulation to TNF-α-induced transcription of
proinflammatory genes in liver epithelial cells. J Immunol.
188:1266–1274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sharma A, Kumar M, Aich J, Hariharan M,
Brahmachari SK, Agrawal A and Ghosh B: Posttranscriptional
regulation of interleukin-10 expression by hsa-miR-106a. Proc Natl
Acad Sci USA. 106:5761–5766. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang M, Liu Q, Mi S, Liang X, Zhang Z, Su
X, Liu J, Chen Y, Wang M, Zhang Y, et al: Both miR-17-5p and
miR-20a alleviate suppressive potential of myeloid-derived
suppressor cells by modulating STAT3 expression. J Immunol.
186:4716–4724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Witwer KW, Sisk JM, Gama L and Clements
JE: MicroRNA regulation of IFN-beta protein expression: Rapid and
sensitive modulation of the innate immune response. J Immunol.
184:2369–2376. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lai L, Song Y, Liu Y, Chen Q, Han Q, Chen
W, Pan T, Zhang Y, Cao X and Wang Q: MicroRNA-92a negatively
regulates Toll-like receptor (TLR)-triggered inflammatory response
in macrophages by targeting MKK4 kinase. J Biol Chem.
288:7956–7967. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Qi J, Qiao Y, Wang P, Li S, Zhao W and Gao
C: MicroRNA-210 negatively regulates LPS-induced production of
proinflammatory cytokines by targeting NF-κB1 in murine
macrophages. FEBS Lett. 586:1201–1207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jennewein C, von Knethen A, Schmid T and
Brüne B: MicroRNA-27b contributes to lipopolysaccharide-mediated
peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA
destabilization. J Biol Chem. 285:11846–11853. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lu TX, Munitz A and Rothenberg ME:
MicroRNA-21 is up-regulated in allergic airway inflammation and
regulates IL-12p35 expression. J Immunol. 182:4994–5002. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhu QY, Liu Q, Chen JX, Lan K and Ge BX:
MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation
of MAPKs in macrophages. J Immunol. 185:7435–7442. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu X, Zhan Z, Xu L, Ma F, Li D, Guo Z, Li
N and Cao X: MicroRNA-148/152 impair innate response and antigen
presentation of TLR-triggered dendritic cells by targeting CaMKIIα.
J Immunol. 185:7244–7251. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ma F, Chen D, Chi Y, Chen F, Li X and Han
Z: The expression and role of miR-301a in human umbilical
cord-derived mesenchymal stromal cells. Cytotherapy. 15:1511–1516.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ozinsky A, Underhill DM, Fontenot JD,
Hajjar AM, Smith KD, Wilson CB, Schroeder L and Aderem A: The
repertoire for pattern recognition of pathogens by the innate
immune system is defined by cooperation between toll-like
receptors. Proc Natl Acad Sci USA. 97:13766–13771. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Pasare C and Medzhitov R: Toll-like
receptors: Linking innate and adaptive immunity. Adv Exp Med Biol.
560:11–18. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hoebe K, Jiang Z, Georgel P, Tabeta K,
Janssen E, Du X and Beutler B: TLR signaling pathways:
Opportunities for activation and blockade in pursuit of therapy.
Curr Pharm Des. 12:4123–4134. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kawai T and Akira S: TLR signaling. Semin
Immunol. 19:24–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
O'Neill LA and Bowie AG: The family of
five: TIR-domain-containing adaptors in Toll-like receptor
signalling. Nat Rev Immunol. 7:353–364. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
DelaRosa O and Lombardo E: Modulation of
adult mesenchymal stem cells activity by toll-like receptors:
Implications on therapeutic potential. Mediators Inflamm.
2010:8656012010. View Article : Google Scholar : PubMed/NCBI
|
